In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
about
Influence of daptomycin on staphylococcal abscesses and experimental tobramycin nephrotoxicityStaphylococcus aureus ventriculitis treated with single-dose intraventricular vancomycin or daptomycin (LY146032): bacterial and antibiotic kinetics in hydrocephalic rabbitsBactericidal activity of vancomycin in cerebrospinal fluidBaseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000-2001Identification of daptomycin-binding proteins in the membrane of Enterococcus hiraeAssessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic modelComparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determinationIn vitro activities of daptomycin (LY146032) and paldimycin (U-70,138F) against anaerobic gram-positive bacteriaEx vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycinActivity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.Activity of LY146032 against Enterococci with and without high-level aminoglycoside resistance, including two penicillinase-producing strainsInvestigation of the early killing of Staphylococcus aureus by daptomycin by using an in vitro pharmacodynamic model.Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis.Therapeutic update on glycopeptide and lipopeptide antibiotics.Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032)Early stages of in vitro killing curve of LY146032 and vancomycin for Staphylococcus aureus.Controlled release of vancomycin from cross-linked gelatine.Comparative in vitro activity of daptomycin (LY146032) and vancomycin against gram-positive cocci determined using a pharmacokinetic model.In-vitro activity of ciprofloxacin and sixteen other antimicrobial agents against blood culture isolates.
P2860
Q28343011-774399AB-0F00-45EC-8701-3BE7AD434A56Q30451719-135E5C62-B028-4CFD-8317-BC68278D5310Q33977378-087D4D8A-B786-468E-B34F-BF7CF5226E1FQ34939045-4F63F063-BA3B-4C2D-825C-F783D996D377Q35118472-D783203C-5852-4121-935D-5B3E10AB8814Q35276965-F321AC67-B1C2-4CBE-B100-D906A25A04CBQ35285000-315DDB6E-CC1D-49C2-91A7-AD396D7C2C21Q35307059-2D9DB8AC-54B6-4205-9060-C5B0BDE90F2CQ35355587-99EB96C8-36B3-4472-97C1-1C7FC780A32AQ35541070-8F8333A2-6A71-4662-837B-B1893C7A9224Q35543452-7635305D-182A-407B-9C3A-4D7CB4623F35Q36757990-39184E19-A515-4E93-8E4B-78D62E525BC4Q37114177-BDF79A53-C713-496A-824C-9B1C7CFF4477Q39291062-5502969B-D6F5-4EE0-BE00-AD7420ADA274Q39816283-B87831CA-9162-4436-AD3C-F9A62E486FF6Q39817922-8DDCF1E4-3C89-4928-8183-68C6A2C4FF28Q43583226-9894AAE4-630E-4886-A745-E10447690DEAQ44672108-F73E7766-4D6B-4CC7-B4BA-53EF8CC70F61Q50164239-F1317AE1-D0F0-4CD9-BDC0-9BF1497F017A
P2860
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
@en
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
@nl
type
label
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
@en
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
@nl
prefLabel
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
@en
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
@nl
P356
P1476
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
@en
P2093
P304
P356
10.1128/AAC.31.2.340
P407
P577
1987-02-01T00:00:00Z